XBIO-F logo

X Bioscience Stock Price

Symbol: THAMSE:XBIO-FMarket Cap: ฿230.8mCategory: Consumer Services

XBIO-F Share Price Performance

฿0.30
0.00 (0.00%)
฿0.30
0.00 (0.00%)
Price ฿0.30

XBIO-F Community Narratives

There are no narratives available yet.

Recent XBIO-F News & Updates

No updates

X Bioscience Public Company Limited Key Details

฿319.2m

Revenue

฿180.6m

Cost of Revenue

฿138.6m

Gross Profit

฿398.8m

Other Expenses

-฿260.2m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.12
Gross Margin
43.42%
Net Profit Margin
-81.51%
Debt/Equity Ratio
31.5%

X Bioscience Public Company Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About XBIO-F

Founded
1984
Employees
n/a
CEO
Saowanee Khaoubol
WebsiteView website
www.wowfactor.co.th

X Bioscience Public Company Limited, together with its subsidiaries, engages in the sale of food and beverages in Thailand. The company’s brands include Kagonoya, Le Boeuf, and Bake Cheese Tart. It also engages in restaurant and energy businesses. In addition, the company manufactures and sells biological products and engages in the energy business. The company was formerly known as Wow Factor Public Company Limited and changed its name to X Bioscience Public Company Limited in January 2025. X Bioscience Public Company Limited was founded in 1984 and is based in Bangkok, Thailand.

Thai Market Performance

  • 7 Days: 1.1%
  • 3 Months: 4.2%
  • 1 Year: -2.9%
  • Year to Date: -8.4%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 7.4% in that time. Similarly, the market is flat for the past 12 months. Earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading